Navigation Links
HCA Reports Fourth Quarter and Year End 2008 Results
Date:2/3/2009

95.9 25,460 94.8 Income before minority interests and income taxes 1,170 4.1 1,398 5.2 Minority interests in earnings of consolidated entities 229 0.8 208 0.8 Income before income taxes 941 3.3 1,190 4.4 Provision for income taxes 268 0.9 316 1.1 Net income $673 2.4 $874 3.3 HCA Inc. Supplemental Operating Results Summary (Dollars in millions) For the Years Fourth Quarter Ended December 31, 2008 2007 2008 2007 Revenues $7,265 $6,883 $28,374 $26,858 Net income $276 $278 $673 $874 Gains on sales of facilities (net of tax) (5) (88) (58) (291) Impairment of long-lived assets (net of tax) 7 -- 41 15 Net income, excluding gains on sales of facilities and impairment of long-lived assets 278 190 656 598 Depreciation and amortization 354 354 1,416 1,426 Interest expense 500 541 2,021 2,215 Minority interests in earnings of consolidated entities 68 48 229 208 Provision for income taxes 37 20 252 145 Adjusted EBITDA (a) $1,237 $1,153 $4,574 $4,592 <
'/>"/>
SOURCE HCA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Perrigo Reports Record Second Quarter Sales
2. Rochester Medical Reports First Quarter Results
3. Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
4. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
5. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009
6. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
7. MDS Files 2008 Annual Reports
8. North State Bancorp Reports Profitable 2008
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
10. Cardiums InnerCool Reports on Expanding Use of Therapeutic Hypothermia
11. Zimmer Reports Fourth Quarter and 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 DW-InductionHeating.com (DaWei Induction Heating Co.) ... and developing, producing and marketing of a series of ... announces their new series of induction brazing equipments ... company, induction brazing refers to the joining ... material and heat. The manager says that there are ...
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... The click strand woven bamboo flooring ... Today, the business announces a click strand woven ... 30, 2015. , Click strand woven bamboo flooring ... a well-known brand in the bamboo industry. It ... reliable bamboo flooring supplier. , “We are happy ...
(Date:12/25/2014)... December 26, 2014 The report “TS-1 ... focuses on the current treatment landscape, unmet needs, current ... TS-1 is an anti-cancer drug which is typically used ... is also used for treating gastric cancer and pancreatic ... potassium. The drug was first approved in 1999 in ...
(Date:12/25/2014)... “Every three months the trends for evening dresses ... will be one of the hottest styles in the next ... the company releases 26 A-line sweetheart evening dresses, and announces ... , “We are trying our best to help a lady ... Along with affordable prices, we provide discounted delivery costs to ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... screening for disease detection, better surgical techniques available to ... reduce the risk of relapse in patients with both ... to dramatic improvements in breast cancer,s survival rates, according ... at The University of Texas MD Anderson Cancer Center. ...
... HOUSTON - Long associated with a worse outcome, researchers ... have discovered that women treated for breast cancer while ... trend for improved overall survival compared to non-pregnant women ... professor in MD Anderson,s Department of Breast Medical Oncology, ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Sept. ... a progestin hormone may be an effective treatment for ... By delaying a total hysterectomy, which is the ... to remain fertile and possibly to have families, according ...
... Reporter , WEDNESDAY, Sept. 29 (HealthDay News) -- A ... knee pain from osteoarthritis, researchers are reporting. But ... phase 3 trial of the drug after 16 patients ... researcher Dr. Nancy E. Lane, director of the Aging ...
... at the University of California, San Diego shows that California,s ... rates that are nearly 25 percent lower than other states. ... population surveys was reassuring" said John P. Pierce, PhD, Sam ... Family and Preventive Medicine at UCSD School of Medicine and ...
... 28, 2010 Although first responders willingly put themselves in ... not be as willing if the disaster is a potentially ... Columbia University,s Mailman School of Public Health found that more ... they surveyed might be absent from work during a serious ...
Cached Medicine News:Health News:MD Anderson study finds increases in 5-, 10-year survival at every stage of breast cancer 2Health News:MD Anderson study finds increases in 5-, 10-year survival at every stage of breast cancer 3Health News:MD Anderson study finds increases in 5-, 10-year survival at every stage of breast cancer 4Health News:UT MD Anderson study finds women treated for breast cancer while pregnant have improved survival 2Health News: IUD Proposed to Treat Uterine Cancer 2Health News: IUD Proposed to Treat Uterine Cancer 3Health News:Novel Drug Eases Osteoarthritis Knee Pain 2Health News:California's leadership in tobacco control results in lower lung cancer rate 2Health News:Less than half of essential workers willing to report to work during a serious pandemic 2Health News:Less than half of essential workers willing to report to work during a serious pandemic 3
(Date:12/22/2014)... , Dec. 22, 2014 Research and ... the addition of the "Investment Analysis of ... to their offering. ... in the US medical device sector identifies the ... and venture capital investments, and mergers and acquisitions. ...
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 ... Pharmaceuticals, Inc. today announced that the Committee for Medicinal ... Agency (EMA) has adopted a positive opinion for the ... of adult men with Peyronie,s disease with a palpable ... at the start of therapy. The use ...
(Date:12/22/2014)... PALO ALTO, Calif. , Dec, 22, 2014 ... of a Phase 2a study of lonafarnib in ...  The study was conducted at the National Institutes ... Bethesda, Maryland .  The double-blinded, randomized, placebo-controlled, ... 100 mg twice daily and 200 mg twice ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... Company remains committed to speeding innovation ... pipeline boasts 70 potential medicines in clinical development, including 33 in ... ten potential new medicines in Phase III by the end of ... such as neuroscience, diabetes and oncology, as well as new areas ...
... MISSISSAUGA, Ontario, June 30, 2011 Valeant Pharmaceuticals ... VRX) announced today that its subsidiary, Valeant International ... acquire rights to both Elidel (pimecrolimus 1% cream) ... Meda, an international specialty pharmaceutical company (listed on ...
Cached Medicine Technology:Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 2Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 3Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 4Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 5Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 6Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 7Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 8Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 9Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 10Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 11Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 12Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 13Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 14Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 15Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations 16Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese™ 2Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese™ 3
Quantel Medical introduces the new Aviso A/B, a new generation high definition ultrasound system in a unique laptop or desktop PC workstation....
... Therapy: ,Full-length air fluidization assists ... greater comfort and accelerated healing of ... be defluidized to facilitate patient positioning ... Reverse Trendelenburg. CPR procedures can be ...
... incisional corneal surgery has long ... of the ophthalmology practice. To ... the technical skills and a ... quality. The new "Newman Astigmatic ...
The new TRC-NW200 Non-Mydriatic Retinal Camera combines Topcons years of experience in retinal imaging with the latest advances in digital and electronic technology....
Medicine Products: